1. Home
  2. KN vs OLMA Comparison

KN vs OLMA Comparison

Compare KN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$24.95

Market Cap

2.0B

ML Signal

N/A

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

N/A

Current Price

$14.86

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KN
OLMA
Founded
1946
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
OLMA
Price
$24.95
$14.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$22.33
$41.13
AVG Volume (30 Days)
553.8K
1.5M
Earning Date
05-08-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
118.94
N/A
EPS
0.50
N/A
Revenue
$593,200,000.00
N/A
Revenue This Year
$9.40
N/A
Revenue Next Year
$6.98
N/A
P/E Ratio
$50.84
N/A
Revenue Growth
7.17
N/A
52 Week Low
$12.19
$2.86
52 Week High
$28.74
$36.26

Technical Indicators

Market Signals
Indicator
KN
OLMA
Relative Strength Index (RSI) 42.02 20.38
Support Level $23.81 $4.35
Resistance Level $25.33 $27.38
Average True Range (ATR) 0.89 1.35
MACD -0.38 -0.95
Stochastic Oscillator 23.93 2.71

Price Performance

Historical Comparison
KN
OLMA

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: